Senate Expands Infant Formula Safety, Supply Workload For FDA, Industry In User Fees Bill

HELP Committee passes five-year reauthorization of FDA drug, medical device and biosimilar user fees with separate provisions expanding agency’s authority to regulate infant formula manufacturing and marketing and establishing Office of Critical Foods in CFSAN.